Endogenous osteoprotegerin (OPG) represses ERα and promotes stemness and chemoresistance in breast cancer cells
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Endogenous osteoprotegerin (OPG) represses ERα and promotes stemness and chemoresistance in breast cancer cells ; volume:10 ; number:1 ; day:24 ; month:8 ; year:2024 ; pages:1-12 ; date:12.2024
Cell death discovery ; 10, Heft 1 (24.8.2024), 1-12, 12.2024
- Creator
-
Alraouji, Noura N.
Colak, Dilek
Al-mohanna, Falah H.
Alaiya, Ayodele A.
Aboussekhra, Abdelilah
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41420-024-02151-8
- URN
-
urn:nbn:de:101:1-2411121026149.273887215644
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.20252025, 4:28 PM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Alraouji, Noura N.
- Colak, Dilek
- Al-mohanna, Falah H.
- Alaiya, Ayodele A.
- Aboussekhra, Abdelilah
- SpringerLink (Online service)
Other Objects (12)
Osteoprotegerin (OPG) as a biomarker for diabetic cardiovascular complications
CPEB1 mediates hepatocellular carcinoma cancer stemness and chemoresistance
Breast cancer cells stimulate osteoprotegerin (OPG) production by endothelial cells through direct cell contact
Effects of osteoprotegerin from transfection of pcDNA3.1(+)/chOPG on bioactivity of chicken osteoclasts
Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseases
Serum proinflammatory cytokines, receptor activator of nuclear factor kappa-Β ligand (RANKL), osteoprotegerin (OPG) and RANKL/OPG ratio in mild and severe COVID-19
OPG Nachsortierung (Bestand)
Regulation von Osteoprotegerin (OPG) und receptor activator of nuclear factor-κB [factor-kappa-B] ligand (RANKL) in humanen Schilddrüsenkarzinomzellen
Osteoprotegerin (OPG) activates integrin, focal adhesion kinase (FAK), and Akt signaling in ovarian cancer cells to attenuate TRAIL-induced apoptosis
Charakterisierung von Osteoprotegerin (OPG) und receptor activator of NF-κB-ligand [NF-kappa-B-ligand] (RANKL) in der Schilddrüse
Offizierpensionsgesetz (O.P.G.) nebst Ausführungsbestimmungen
AKAP8L enhances the stemness and chemoresistance of gastric cancer cells by stabilizing SCD1 mRNA
Osteoprotegerin (OPG) as a biomarker for diabetic cardiovascular complications
CPEB1 mediates hepatocellular carcinoma cancer stemness and chemoresistance
Breast cancer cells stimulate osteoprotegerin (OPG) production by endothelial cells through direct cell contact
Effects of osteoprotegerin from transfection of pcDNA3.1(+)/chOPG on bioactivity of chicken osteoclasts
Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseases
Serum proinflammatory cytokines, receptor activator of nuclear factor kappa-Β ligand (RANKL), osteoprotegerin (OPG) and RANKL/OPG ratio in mild and severe COVID-19
OPG Nachsortierung (Bestand)
Regulation von Osteoprotegerin (OPG) und receptor activator of nuclear factor-κB [factor-kappa-B] ligand (RANKL) in humanen Schilddrüsenkarzinomzellen
Osteoprotegerin (OPG) activates integrin, focal adhesion kinase (FAK), and Akt signaling in ovarian cancer cells to attenuate TRAIL-induced apoptosis
Charakterisierung von Osteoprotegerin (OPG) und receptor activator of NF-κB-ligand [NF-kappa-B-ligand] (RANKL) in der Schilddrüse
Offizierpensionsgesetz (O.P.G.) nebst Ausführungsbestimmungen
AKAP8L enhances the stemness and chemoresistance of gastric cancer cells by stabilizing SCD1 mRNA
Osteoprotegerin (OPG) as a biomarker for diabetic cardiovascular complications
CPEB1 mediates hepatocellular carcinoma cancer stemness and chemoresistance
Breast cancer cells stimulate osteoprotegerin (OPG) production by endothelial cells through direct cell contact
Effects of osteoprotegerin from transfection of pcDNA3.1(+)/chOPG on bioactivity of chicken osteoclasts
Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseases
Serum proinflammatory cytokines, receptor activator of nuclear factor kappa-Β ligand (RANKL), osteoprotegerin (OPG) and RANKL/OPG ratio in mild and severe COVID-19
OPG Nachsortierung (Bestand)
Regulation von Osteoprotegerin (OPG) und receptor activator of nuclear factor-κB [factor-kappa-B] ligand (RANKL) in humanen Schilddrüsenkarzinomzellen
Osteoprotegerin (OPG) activates integrin, focal adhesion kinase (FAK), and Akt signaling in ovarian cancer cells to attenuate TRAIL-induced apoptosis
Charakterisierung von Osteoprotegerin (OPG) und receptor activator of NF-κB-ligand [NF-kappa-B-ligand] (RANKL) in der Schilddrüse
Offizierpensionsgesetz (O.P.G.) nebst Ausführungsbestimmungen